ArticleTranslational lung cancer research2024

REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer?

Julie Dardare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.